| Parotid-sparing intensity modulated versus conventional radiotherapy in head and neck cancer (PARSPORT): a phase 3 multicentre randomised controlled trial CM Nutting, JP Morden, KJ Harrington, TG Urbano, SA Bhide, C Clark, ... The lancet oncology 12 (2), 127-136, 2011 | 1985 | 2011 |
| Sorafenib in radioactive iodine-refractory, locally advanced or metastatic differentiated thyroid cancer: a randomised, double-blind, phase 3 trial MS Brose, CM Nutting, B Jarzab, R Elisei, S Siena, L Bastholt, ... The Lancet 384 (9940), 319-328, 2014 | 1816* | 2014 |
| Radiotherapy plus cisplatin or cetuximab in low-risk human papillomavirus-positive oropharyngeal cancer (De-ESCALaTE HPV): an open-label randomised controlled phase 3 trial H Mehanna, M Robinson, A Hartley, A Kong, B Foran, T Fulton-Lieuw, ... The Lancet 393 (10166), 51-60, 2019 | 1052 | 2019 |
| Delineation of the neck node levels for head and neck tumors: a 2013 update. DAHANCA, EORTC, HKNPCSG, NCIC CTG, NCRI, RTOG, TROG consensus guidelines V Grégoire, K Ang, W Budach, C Grau, M Hamoir, JA Langendijk, A Lee, ... Radiotherapy and Oncology 110 (1), 172-181, 2014 | 870 | 2014 |
| Ablation with low-dose radioiodine and thyrotropin alfa in thyroid cancer U Mallick, C Harmer, B Yap, J Wadsley, S Clarke, L Moss, A Nicol, ... New England Journal of Medicine 366 (18), 1674-1685, 2012 | 762 | 2012 |
| A phase I study of OncoVEXGM-CSF, a second-generation oncolytic herpes simplex virus expressing granulocyte macrophage colony-stimulating factor JCC Hu, RS Coffin, CJ Davis, NJ Graham, N Groves, PJ Guest, ... Clinical cancer research 12 (22), 6737-6747, 2006 | 689 | 2006 |
| PET-CT surveillance versus neck dissection in advanced head and neck cancer H Mehanna, WL Wong, CC McConkey, JK Rahman, M Robinson, ... New England Journal of Medicine 374 (15), 1444-1454, 2016 | 677 | 2016 |
| CT-based delineation of organs at risk in the head and neck region: DAHANCA, EORTC, GORTEC, HKNPCSG, NCIC CTG, NCRI, NRG Oncology and TROG consensus guidelines CL Brouwer, RJHM Steenbakkers, J Bourhis, W Budach, C Grau, ... Radiotherapy and Oncology 117 (1), 83-90, 2015 | 646 | 2015 |
| Stereotactic body radiotherapy for oligometastases AC Tree, VS Khoo, RA Eeles, M Ahmed, DP Dearnaley, MA Hawkins, ... The lancet oncology 14 (1), e28-e37, 2013 | 590 | 2013 |
| Head and neck cancer—Part 1: Epidemiology, presentation, and prevention H Mehanna, V Paleri, CML West, C Nutting Bmj 341, 2010 | 448 | 2010 |
| Phase I/II Study of Oncolytic HSVGM-CSF in Combination with Radiotherapy and Cisplatin in Untreated Stage III/IV Squamous Cell Cancer of the Head and Neck KJ Harrington, M Hingorani, MA Tanay, J Hickey, SA Bhide, PM Clarke, ... Clinical cancer research 16 (15), 4005-4015, 2010 | 316 | 2010 |
| Phase III pilot study of dose escalation using conformal radiotherapy in prostate cancer: PSA control and side effects DP Dearnaley, E Hall, D Lawrence, RA Huddart, R Eeles, CM Nutting, ... British journal of cancer 92 (3), 488-498, 2005 | 308 | 2005 |
| Reduction of small and large bowel irradiation using an optimized intensity-modulated pelvic radiotherapy technique in patients with prostate cancer CM Nutting, DJ Convery, VP Cosgrove, C Rowbottom, AR Padhani, ... International Journal of Radiation Oncology* Biology* Physics 48 (3), 649-656, 2000 | 305 | 2000 |
| Intensity modulated radiation therapy: a clinical review. C Nutting, DP Dearnaley, S Webb The British journal of radiology 73 (869), 459-469, 2000 | 304 | 2000 |
| Weekly volume and dosimetric changes during chemoradiotherapy with intensity-modulated radiation therapy for head and neck cancer: a prospective observational study SA Bhide, M Davies, K Burke, HA McNair, V Hansen, Y Barbachano, ... International Journal of Radiation Oncology* Biology* Physics 76 (5), 1360-1368, 2010 | 274 | 2010 |
| HPV-related oropharynx cancer in the United Kingdom: an evolution in the understanding of disease etiology AG Schache, NG Powell, KS Cuschieri, M Robinson, S Leary, H Mehanna, ... Cancer research 76 (22), 6598-6606, 2016 | 229 | 2016 |
| Intensity-modulated radiotherapy in patients with locally advanced rectal cancer reduces volume of bowel treated to high dose levels MTG Urbano, AJ Henrys, EJ Adams, AR Norman, JL Bedford, ... International Journal of Radiation Oncology* Biology* Physics 65 (3), 907-916, 2006 | 226 | 2006 |
| Analysis of the efficacy and toxicity of sorafenib in thyroid cancer: a phase II study in a UK based population M Ahmed, Y Barbachano, A Riddell, J Hickey, KL Newbold, A Viros, ... European Journal of Endocrinology 165 (2), 315-322, 2011 | 224 | 2011 |
| A comparison of conformal and intensity-modulated techniques for oesophageal radiotherapy CM Nutting, JL Bedford, VP Cosgrove, DM Tait, DP Dearnaley, S Webb Radiotherapy and Oncology 61 (2), 157-163, 2001 | 220 | 2001 |
| Recent advances in radiotherapy SA Bhide, CM Nutting BMC medicine 8, 1-5, 2010 | 211 | 2010 |
